Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Denmark
/
Erik Kromann
EK
Erik Kromann
DK
0 active roles
Share
Overview
Companies & roles
Network
Loading profile…
Erik Kromann is a Danish director.
Overview
Active roles
0
directorships & management
Past roles
36
historical positions
Dissolved companies
27
in directorship history
Career timeline
2015 – 2017
Chairman, BIOCARE COPENHAGEN A/S
2013 – 2016
Board of Directors, SEPTICHEM ApS
2012 – 2016
Chairman, DECUMED ApS
2008 – 2010
Chairman, COMMERCIALIZATION AND LICENSING A/S
2007 – 2007
Management, BIONANOPHOTONICS A/S
2007 – 2007
Board of Directors, ANAPA BIOTECH A/S
2006 – 2008
Chairman, CLLUONE DIAGNOSTICS A/S
2006 – 2007
Chairman, TKS ApS
2006 – 2007
Board of Directors, DITENS A/S
2006 – 2007
Chairman, IN SITU RCP A/S
2006 – 2007
Chairman, DHI TOXISPOT A/S
2006 – 2007
Board of Directors, SCAPE TECHNOLOGIES A/S
2005 – 2007
Board of Directors, HOPRO A/S
2005 – 2007
Chairman, NEMOMED A/S
2005 – 2007
Chairman, NANOFIBER A/S
2005 – 2006
Chairman, T-SHIFT A/S
2004 – 2006
Board of Directors, BEAMCONTROL ApS
2004 – 2006
Chairman, KRILL A/S
2003 – 2011
Board of Directors, ILOCHIP A/S
2003 – 2007
Management, NOVI INNOVATION A/S
2003 – 2007
Board of Directors, CYM1P A/S
2003 – 2005
Board of Directors, MERMAID CARE A/S
2003 – 2003
Board of Directors, VIDENKAPITAL ApS
2002 – 2008
Chairman, SUPERTRÆ A/S
2002 – 2004
Board of Directors, NETIC A/S
2001 – 2012
Founder, NORDIC VACCINE A/S
2001 – 2012
Chief Executive Officer, MOLUK ApS
2001 – 2003
Board of Directors, BIO FUND MANAGEMENT A/S
2000 – 2001
Board of Directors, XENOGENIX ApS
1997 – 1999
Management, GX BIOSYSTEMS A/S
1995 – 1996
Board of Directors, KEMI-SALEX A/S
1995 – 1996
Management, BRENNTAG BIOSECTOR A/S
1988 – 1993
Board of Directors, SCANPHARM A/S
1988 – 1993
Board of Directors, KLEK A/S
1988 – 1993
Board of Directors, GENEC A/S
1988 – 1993
Board of Directors, PANNI A/S
Personal details
Nationality
DK
More on Erik Kromann
Companies & roles →
Active and historical directorships
Network →
Connections across other directors and entities
